Quantitative multivoxel proton chemical shift imaging of the breast

Magnetic Resonance Imaging

Volumn 28, Issue 3, 2010, Pages 314-319

  Sijens, Paul E ^a   Dorrius, Monique D ^a   Kappert, Peter ^a   Baron, Paul ^a   Pijnappel, Ruud M ^a   Oudkerk, Matthijs ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Breast cancer; Choline; Magnetic resonance spectroscopy

Indexed keywords

CHOLINE; CREATININE; GADOLINIUM; WATER;

ADULT; ARTICLE; BREAST; BREAST CANCER; CASE REPORT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; RELAXATION TIME; SIGNAL NOISE RATIO; TISSUE CHARACTERIZATION;

ALGORITHMS; BREAST; BREAST NEOPLASMS; CHOLINE; DIAGNOSIS, COMPUTER-ASSISTED; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; PROTONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 77649336943     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2009.11.004     Document Type: Article

References (36)

1. 31P MR spectroscopy at 1.5T. Radiology 169 (1988) 615-620
2. 1H MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging 8 (1998) 1191-1197
3. Roebock J.R., Cecil K.M., Schnall M.D., and Linkenski R.E. Human breast lesions: characterization with proton MR spectroscopy. Radiology 209 (1998) 269-275
4. Young D.K.W., Cheung H.S., and Tse C.M.K. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy - initial results. Radiology 220 (2001) 40-46
5. Cecil K.M., Schnall M.D., Siegelman E.S., and Lenkinski R.E. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 68 (2001) 45-54
6. Jagannathan N.R., Kumar M., Seenu M.K., Coshic O., Dwivedi S.N., Julka P.K., et al. Evaluation of total choline from in-vivo volume localized spectroscopy and its response to neoadjuvant chemotherapy in locally advance breast cancer. Br J Cancer 84 (2001) 1016-1022
7. 1H MR spectroscopy. Magn Reson Med 50 (2003) 1134-1143
8. Huang W., Fischer P.R., Dulaimy K., Tudorica L.A., O'Hea B., and Button T.M. Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology 232 (2004) 585-591
9. Lee J., Yamaguchi T., Abe A., Shizukuishi K., Uemura H., Miyagi E., et al. Clinical evaluation of choline measurement by proton MR spectroscopy in patients with malignant tumors. Radiat Med 22 (2004) 148-154
10. 1H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administration. Invest Radiol 40 (2005) 405-411
11. 1H MRS at 1.5T. Eur Radiol 15 (2005) 1037-1043
12. 1H MR spectroscopy using water as an internal reference at 1.5 T. MAGMA 19 (2006) 96-104
13. Bartella L., Morris E.A., Dershaw D.D., Liberman L., Thakur S.B., Moskowitz C., et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis. Radiology 239 (2006) 686-692
14. Bartella L., Thakur S.B., Morris E.A., Dershaw D.D., Huang W., Chough E., et al. Enhancing non-mass lesions in the breast: evaluation with proton MR spectroscopy. Radiology 245 (2007) 80-87
15. 1H MRS of the breast: presence of a choline peak as malignancy marker is related to k21 value of the tumor in patients with invasive ductal carcinoma. Breast J 14 (2008) 574-580
16. Baek H.M., Chen J.H., Nalcioglu O., and Su M.Y. Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapy. Annals Oncol 19 (2008) 1022-1024
17. Jacobs M.A., Barker P.B., Argani P., Ouwerkerk R., Bhujwalla Z.M., and Bluemke D.A. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imaging 21 (2005) 23-28
18. Su M.Y., Baik H.M., Yu H.J., Chen J.M., Mehta R.S., and Nalcioglu O. Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI. Technol Cancer Res Treat 5 (2006) 401-410
19. Stanwell P., and Mountford C. In vivo proton MR spectroscopy of the breast. Radiographics 27 (2007) S253-S266
20. Baek H.M., Chen J.H., Yu H.J., Mehta R., Nalcioglu O., and Su M.Y. Detection of choline signal in human breast lesions with chemical shift imaging. J Magn Reson Imaging 27 (2008) 1114-1121
21. Bottomley P.A. Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 508 (1987) 333-348
22. Ordidge R.J., Mansfield P., Lohman J.A., and Prime S.B. Volume selection using gradients and selective pulses. Ann NY Acad Sci 508 (1987) 376-385
23. Mao J., Mareci T.H., and Andrew E.R. Experimental study of optimal selective 180° radiofrequency pulses. J Magn Reson 79 (1988) 1-10
24. Mescher M., Tannus A., O'Neil Johnson M., and Garwood M. Solvent suppression using selective echo dephasing. J Magn Reson A 123 (1996) 226-229
25. Star-Lack J., Nelson S.J., Kurhanewicz J., Huang L.R., and Vigneron D.B. Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med 38 (1997) 311-321
26. Ogg R.J., Kingsley P.B., and Taylor J.S. WET, a T1- and B1-insensitive water-suppression method for in vivo localized spectroscopy. J Magn Reson B 104 (1994) 1-10
27. Irwan R., Edens M.A., and Sijens P.E. Assessment of the variations in fat content in normal liver using a fast quantitative MR imaging method in comparison with results obtained by spectroscopic imaging. Eur Radiol 18 (2008) 806-813
28. Chen J.H., Avram H.E., Crooks L.E., Arakawa M., Kaufman L., and Brito A.C. In vivo relaxation times and hydrogen density at 0.063-4.85 T in rats with implanted mammary adenocarcinomas. Radiology 184 (1992) 427-434
29. Graham S.J., Ness S., Hamilton B.S., and Bronskill M.J. Magnetic resonance properties of ex vivo breast tissue at 1.5 T. Magn Reson Med 38 (1997) 669-677
30. Rakow-Penner R., Daniel B., Yu H., Sawyer-Glover A., and Glover G.H. Relaxation times of breast tissue at 1.5 T and 3 T measured using IDEAL. J Magn Reson Imaging 23 (2006) 87-91
31. 1H Chemical shift imaging characterization of human brain tumor and edema. Eur Radiol 12 (2002) 2056-2061
32. Bakken I.J., Gribbestad I.S., Singstad T.E., and Kvistad K.A. External standard method for the in vivo quantification of choline containing compounds in breast tumors by proton MR spectroscopy at 1.5 tesla. Magn Reson Med 46 (2001) 189-192
33. Sijens P.E., and Oudkerk M. Clinical magnetic resonance spectroscopy. Imaging Decis MRI 9 (2005) 39-48
34. 1H MR spectroscopy detection of lipids and lactate in metastatic brain tumors. NMR Biomed 9 (1996) 65-71
35. 1H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings. Eur Radiol 16 (2006) 489-495
36. Tan P.C., Pickles M.D., Lowry M., Manton D.J., and Turnbull L.W. Lesion T2 relaxation times and volumes predict the response of malignant breast lesions to neoadjuvant chemotherapy. Magn Reson Imaging 26 (2008) 26-34